Abstract:Background
Ibrutinib, a Bruton Tyrosine Kinase inhibitor (iBTK), binds with target protein to arrest B-cell development and decrease microglia activation. Considering the emerging role of B and microglial cells in multiple sclerosis (MS) pathology, BTK inhibition is being considered a novel therapeutic strategy.
Objective
To investigate the effects of Ibrutinib on the disease pathology and clinical disability of the Theiler’s Murine Encephalomyelitis Virus (TMEV) mouse model of MS.
Methods
Twenty-six TMEV i… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.